Etiological and Clinical Characteristics of Hepatocellular Carcinoma at Presentation to Tertiary Care Hospital in South India

2016 ◽  
Vol 6 ◽  
pp. S70-S71
Author(s):  
Chethan Govindaraju ◽  
Prasanth Sudheendran ◽  
Nikhil Suraj ◽  
Gunjal Sudamrao ◽  
Singh Anirudha Pratap ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Characteristics ◽  
South India ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Care Hospital

A Retrospective Study on Clinical Characteristics of Hepatocellular Carcinoma in a Tertiary Care Hospital

2011 ◽  
Vol 4 (6) ◽  
pp. 404-405
Author(s):  
Dr.K.Narayanasamy Dr.K.Narayanasamy ◽  
◽  
R.Parvathavarthini R.Parvathavarthini ◽  
Dr.A.Chezhian Dr.A.Chezhian ◽  
Dr.R.Senthil Kumar
Keyword(s):  
Hepatocellular Carcinoma ◽  
Retrospective Study ◽  
Clinical Characteristics ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Care Hospital

Hepatocellular carcinoma continues to be diagnosed in the advanced stage: profile of hepatocellular carcinoma in a tertiary care hospital in South India

2013 ◽  
Vol 43 (1) ◽  
pp. 25-26 ◽  
Author(s):  
Sandip Pal ◽  
Jeyamani Ramachandran ◽  
Reuben Thomas Kurien ◽  
Anu Eapen ◽  
Banumathi Ramakrishna ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
South India ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Care Hospital ◽  
Advanced Stage

SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences

2020 ◽  
Vol 14 (10) ◽  
pp. 855-867
Author(s):  
Filippo Pelizzaro ◽  
Federica Soldà ◽  
Romilda Cardin ◽  
Angela Imondi ◽  
Anna Sartori ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Transarterial Chemoembolization ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Immunoglobulin M ◽  
Care Hospital ◽  
Squamous Cell Carcinoma Antigen ◽  
Preclinical Models ◽  
Relevant Variable ◽  
Gender Specific

Aim: Squamous cell carcinoma antigen immune complexed with immunoglobulin M (SCCA-IgM) is a useful but not completely satisfactory biomarker of hepatocellular carcinoma (HCC). Considering its gender-specific behavior in preclinical models, we investigated gender-related differences of SCCA-IgM as a prognostic marker in HCC. Patients & methods: Two hundred and eight prospectively recruited patients treated with transarterial chemoembolization in a single tertiary care hospital were retrospectively evaluated. Correlations between SCCA-IgM levels, clinical characteristics and survival were assessed according to gender. Results: When the disease was advanced, SCCA-IgM was higher in males and lower in females. Levels below 130 AU/ml predicted a significantly longer survival in males (p = 0.007) and a shorter survival in females (p = 0.01). Conclusion: In predicting the prognosis of HCC patients, the interpretation of SCCA-IgM should consider gender as a relevant variable.

Sign in / Sign up

Export Citation Format

Share Document